A detailed description of topoisomerase inhibitors (irinotecan,
etoposide) that are currently used in routine therapy or are in
clinical trials in breast cancer patients.
In « Molecular Therapy of Breast Cancer: Classicism Meets Modernity ».
by Marc Lacroix
InTextoResearch, Baelen (Liège, Wallonia), Belgium
Nova Sciences Publishers, New York, ISBN 978-1-60741-593-0